Lionsgate director granted 6,303 common shares
Ostolaza Yvette reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Ostolaza Yvette reported acquisition or exercise transactions in this Form 4 filing.
Lionsgate Studios Corp. director Yvette Ostolaza received a grant of 6,303 common shares on a compensation basis, valued at $9.52 per share. This was classified as a grant or award, not an open-market purchase.
After this award, she directly holds 147,820 common shares. Her holdings also include 20,107 restricted share units granted by the company, which are scheduled to vest on November 28, 2026, and will be payable in an equal number of common shares upon vesting.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares | 6,303 | $9.52 | $60K |
Footnotes (2)
- F1. Director fees paid in common shares.
- F2. Amount includes 20,107 restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer, that are scheduled to vest on November 28, 2026.
Key Figures
Key Terms
director fees financial
grant, award, or other acquisition financial
vesting financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Lionsgate Studios (LION) director Yvette Ostolaza report in this Form 4?
Was the Lionsgate (LION) Form 4 transaction a stock purchase or a grant?
How is director compensation structured in this Lionsgate Studios (LION) Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.